SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-014711
Filing Date
2023-08-14
Accepted
2023-08-14 07:45:42
Documents
55
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q xlo-20230630x10q.htm   iXBRL 10-Q 1620581
2 EX-10.1 xlo-20230630xex10d1.htm EX-10.1 17032
3 EX-31.1 xlo-20230630xex31d1.htm EX-31.1 12291
4 EX-31.2 xlo-20230630xex31d2.htm EX-31.2 12184
5 EX-32.1 xlo-20230630xex32d1.htm EX-32.1 8162
  Complete submission text file 0001558370-23-014711.txt   4995459

Data Files

Seq Description Document Type Size
6 EX-101.SCH xlo-20230630.xsd EX-101.SCH 27634
7 EX-101.CAL xlo-20230630_cal.xml EX-101.CAL 34388
8 EX-101.DEF xlo-20230630_def.xml EX-101.DEF 125634
9 EX-101.LAB xlo-20230630_lab.xml EX-101.LAB 294203
10 EX-101.PRE xlo-20230630_pre.xml EX-101.PRE 234601
49 EXTRACTED XBRL INSTANCE DOCUMENT xlo-20230630x10q_htm.xml XML 574791
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40925 | Film No.: 231166324
SIC: 2834 Pharmaceutical Preparations